MedTrace Logo

Healing of Ischemic Leg Ulcers in Patients Treated With iSONIAzid

NCT04802928 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2021-03-19

No results posted yet for this study

Summary

The main objective of this trial is to study the healing effect of an oral drug (isoniazid) in patients with ischemic (arterial) leg ulcers defined by a systolic toe pressure \<40 mm Hg.

Conditions

  • Arterial Leg Ulcer

Interventions

DRUG

Isoniazid 300 milligram

Tablets 150 milligram b.i.d.

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Pharma 2100

    lead INDUSTRY

Principal Investigators

  • Tonny Karlsmark, MD, PhD · Bispebjerg Hospital, Copenhagen, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2008-09-30
Completion
2008-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04802928 on ClinicalTrials.gov